S. Kh. Soltanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
S. Kh. Soltanov has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alexey Ulitin
Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre
2 shared publications - A. N. Nazarbekov
Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre
1 shared publication - A. P. Svyatochevskaya
FSBEI HE I.N. Ulyanov Chuvash State University of the Ministry of Education and Science of the Russian Federation, 15 Moskovskiy ave., Cheboksary, 428015, Russia
1 shared publication - A. V. Vasilenko
Almazov National Medical Research Center; Mechnikov North-Western State Medical University
1 shared publication - Aleksandr Z. Gagiev
Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre
1 shared publication - Andrey Eugenievich Petrov
Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia
1 shared publication
Latest Publications
- 30 September 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 09,p. 1553-1566
Aseptic meningitis in patients after posterior cranial fossa surgery
Surgical interventions in the posterior cranial fossa are associated with a high risk of aseptic meningitis and pseudomeningocele, which are considered in the current literature as independent complications. The aim of the study was to determine the relationship between aseptic meningitis and pseudomeningocele, as well as to evaluate the effect of autocranioplasty on the risk and course of these pathological processes. A retro-prospective study included 119 patients who underwent posterior fossa surgery from 2015 to 2025. Aseptic meningitis developed in 24 (20.2 %) patients, pseudomeningocele — in 15 (12.6 %). Clinical and laboratory parameters, cerebrospinal fluid pressure, length of hospitalization, type of craniotomy and dural closure integrity were assessed. Statistical analysis was performed using Fisher’s exact test, Pearson’s chi-square test and Mann — Whitney U test. It was found that 80 % of patients with pseudomeningocele developed aseptic meningitis; the odds of absence of pseudomeningocele in the group without aseptic meningitis were 30.667 times lower (95 % CI: 7.556‑124.470; p<0.001). High cerebrospinal fluid pressure was detected in 86.7 % of patients with pseudomeningocele (p<0.001). Bone-plastic craniotomy with watertight dural closure significantly reduced the risk of pseudomeningocele (p<0.007). A clinical case demonstrates that resolution of aseptic meningitis occurs after the formation of a fibrous capsule of pseudomeningocele, which eliminates the contact of cerebrospinal fluid with muscle tissue breakdown products. Conclusion: aseptic meningitis and pseudomeningocele are pathogenetically interrelated complications forming a «vicious cycle»; boneplastic craniotomy is effective only in the setting of watertight dural closure
- 30 September 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 09,p. 1553-1566
Aseptic meningitis in patients after posterior cranial fossa surgery
Surgical interventions in the posterior cranial fossa are associated with a high risk of aseptic meningitis and pseudomeningocele, which are considered in the current literature as independent complications. The aim of the study was to determine the relationship between aseptic meningitis and pseudomeningocele, as well as to evaluate the effect of autocranioplasty on the risk and course of these pathological processes. A retro-prospective study included 119 patients who underwent posterior fossa surgery from 2015 to 2025. Aseptic meningitis developed in 24 (20.2 %) patients, pseudomeningocele — in 15 (12.6 %). Clinical and laboratory parameters, cerebrospinal fluid pressure, length of hospitalization, type of craniotomy and dural closure integrity were assessed. Statistical analysis was performed using Fisher’s exact test, Pearson’s chi-square test and Mann — Whitney U test. It was found that 80 % of patients with pseudomeningocele developed aseptic meningitis; the odds of absence of pseudomeningocele in the group without aseptic meningitis were 30.667 times lower (95 % CI: 7.556‑124.470; p<0.001). High cerebrospinal fluid pressure was detected in 86.7 % of patients with pseudomeningocele (p<0.001). Bone-plastic craniotomy with watertight dural closure significantly reduced the risk of pseudomeningocele (p<0.007). A clinical case demonstrates that resolution of aseptic meningitis occurs after the formation of a fibrous capsule of pseudomeningocele, which eliminates the contact of cerebrospinal fluid with muscle tissue breakdown products. Conclusion: aseptic meningitis and pseudomeningocele are pathogenetically interrelated complications forming a «vicious cycle»; boneplastic craniotomy is effective only in the setting of watertight dural closure
- Open Access
- 5 November 2024
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 16 (3) , 83-94
Results of total transvenous embolisation of supratentorial cerebral arteriovenous malformations
INTRODUCTION. The efficacy and safety of transvenous embolisation in the treatment of cerebral arteriovenous malformations (AVMs) remain poorly understood, given the very limited number of reported cases. This prospective study was conducted to evaluate this technique in the treatment of cerebral AVMs.MATERIALS AND METHODS. From January 2018 to December 2023, 53 patients with cerebral AVMs who underwent transvenous or transvenous-transarterial (combined) total embolisation were examined at the Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre. AVMs were divided according to the Spetzler – Martin classification: gradation I was in 3 (5.7 %) AVMs , II in 13 (24.5 %), III in 26 ( 49.1 %), IV in 8 (15.1 %), and V in 3 (5.7 %). The mean age of the patients was 37.94±11.13 (range 19-66). The sex ratio M:W was 49.1:50.9%. The mean embolisation stage was 2 (range 1–13). The incidence of complete AVM occlusion was calculated based on DSA images obtained immediately postoperatively and 6–12 months after surgery. The occurrence of haemorrhages and infarcts after embolisation was assessed by CT and MRI immediately after surgery and at 1 month after total embolisation. The mRS scale was used to assess functional outcomes.RESULTS. Complete AVM obliteration was noted in 46 (86.8 %) of 53 patients after embolisation, in 5 (9.4 %) patients total AVM obliteration was achieved with a combination of endovascular and microsurgical treatment. Of 53 patients 2 (3.8 %) died. Postoperative intracranial haemorrhages were detected in 10 (18.9 %). Functional outcomes were assessed: the proportion of patients with mRS ≤2 decreased from 94.2 % (49/53), before embolisation to 82.9 % (44/53) after embolisation, mRS 3–4 =5.7 % (3/53) before embolisation, after 11.3 % (6/53); mRS 5 = 1.9 % (1/53). The mRS scores at the time of follow-up angiography mRS ≤2 90.1 % (46/51), mRS 3–5 =9.9 % (6/51). The percentage of good results (mRS ≤2) in the remote period increased by 7.2 % from 82.9 % (44/53) to 90.1 % (46/51), the percentage of poor results decreased by 3.3 % mRS 3–5 from 13.2 % to 9.9 %.CONCLUSION. Transvenous embolisation can be performed as an independent technique for total occlusion of cerebral AVMs with a high rate of complete obliteration, improved functional outcomes and acceptable morbidity and mortality, but it should be considered mainly as the method of choice when performing the final stage of multistage embolisation.
- 5 November 2024
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 16 (3) , 83-94
Open AccessResults of total transvenous embolisation of supratentorial cerebral arteriovenous malformations
INTRODUCTION. The efficacy and safety of transvenous embolisation in the treatment of cerebral arteriovenous malformations (AVMs) remain poorly understood, given the very limited number of reported cases. This prospective study was conducted to evaluate this technique in the treatment of cerebral AVMs.MATERIALS AND METHODS. From January 2018 to December 2023, 53 patients with cerebral AVMs who underwent transvenous or transvenous-transarterial (combined) total embolisation were examined at the Polenov Neurosurgery Institute – the branch of Almazov National Medical Research Centre. AVMs were divided according to the Spetzler – Martin classification: gradation I was in 3 (5.7 %) AVMs , II in 13 (24.5 %), III in 26 ( 49.1 %), IV in 8 (15.1 %), and V in 3 (5.7 %). The mean age of the patients was 37.94±11.13 (range 19-66). The sex ratio M:W was 49.1:50.9%. The mean embolisation stage was 2 (range 1–13). The incidence of complete AVM occlusion was calculated based on DSA images obtained immediately postoperatively and 6–12 months after surgery. The occurrence of haemorrhages and infarcts after embolisation was assessed by CT and MRI immediately after surgery and at 1 month after total embolisation. The mRS scale was used to assess functional outcomes.RESULTS. Complete AVM obliteration was noted in 46 (86.8 %) of 53 patients after embolisation, in 5 (9.4 %) patients total AVM obliteration was achieved with a combination of endovascular and microsurgical treatment. Of 53 patients 2 (3.8 %) died. Postoperative intracranial haemorrhages were detected in 10 (18.9 %). Functional outcomes were assessed: the proportion of patients with mRS ≤2 decreased from 94.2 % (49/53), before embolisation to 82.9 % (44/53) after embolisation, mRS 3–4 =5.7 % (3/53) before embolisation, after 11.3 % (6/53); mRS 5 = 1.9 % (1/53). The mRS scores at the time of follow-up angiography mRS ≤2 90.1 % (46/51), mRS 3–5 =9.9 % (6/51). The percentage of good results (mRS ≤2) in the remote period increased by 7.2 % from 82.9 % (44/53) to 90.1 % (46/51), the percentage of poor results decreased by 3.3 % mRS 3–5 from 13.2 % to 9.9 %.CONCLUSION. Transvenous embolisation can be performed as an independent technique for total occlusion of cerebral AVMs with a high rate of complete obliteration, improved functional outcomes and acceptable morbidity and mortality, but it should be considered mainly as the method of choice when performing the final stage of multistage embolisation.
- Open Access
- 20 June 2024
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 16 (2) , 157-168
Stigmatization of epilepsy
Epilepsy belongs to one of the most ancient diseases. From the days of yore, patients suffering from epilepsy faced stigma and discrimination because medical knowledge at that time was limited so that such condition was associated with various mystical and mythical phenomena, with no treatment available. The article extensively examines the issue of epilepsy stigma, covering the long history of the disease and highlighting stigma as a serious social problem. Many epileptic patients suffer not only from the disease symptoms but also from social discrimination, which profoundly lowers their quality of life and leads to social maladjustment. Unfortunately, epilepsy stigma has not disappeared completely and persists not only in developing but also in developed countries. We demonstrate the relevance of the problem and the need to increase relevant awareness. The times when epileptic patients were considered possessed by evil spirits and incurable are long gone, so any form of social discrimination against such people is unacceptable in modern society.
- 20 June 2024
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 16 (2) , 157-168
Open AccessStigmatization of epilepsy
Epilepsy belongs to one of the most ancient diseases. From the days of yore, patients suffering from epilepsy faced stigma and discrimination because medical knowledge at that time was limited so that such condition was associated with various mystical and mythical phenomena, with no treatment available. The article extensively examines the issue of epilepsy stigma, covering the long history of the disease and highlighting stigma as a serious social problem. Many epileptic patients suffer not only from the disease symptoms but also from social discrimination, which profoundly lowers their quality of life and leads to social maladjustment. Unfortunately, epilepsy stigma has not disappeared completely and persists not only in developing but also in developed countries. We demonstrate the relevance of the problem and the need to increase relevant awareness. The times when epileptic patients were considered possessed by evil spirits and incurable are long gone, so any form of social discrimination against such people is unacceptable in modern society.